FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077722 [Registered on: 05/12/2024] Trial Registered Prospectively
Last Modified On: 03/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of interventions Gandirikadi tailam and Vajraka kashaya in participants having black thickened skin lesions with itching 
Scientific Title of Study   Effect of topical application of Gandirikadi tailam along with oral administration of Vajraka kashaya in the management of Kitibha with special reference to Cutaneous Lichen Planus  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SUKHMI A S 
Designation  MD Scholar 
Affiliation  Govt Ayurveda College Thiruvananthapuram  
Address  Department of Agadatantra Govt Ayurveda College Thiruvananthapuram Kerala

Thiruvananthapuram
KERALA
695001
India 
Phone  9400049752  
Fax    
Email  sukhmiabdulkhadar1990@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SHIJI R S 
Designation  Professor and HOD 
Affiliation  Govt Ayurveda College Thiruvananthapuram 
Address  Department of Agadatantra Govt Ayurveda College Thiruvananthapuram Kerala

Thiruvananthapuram
KERALA
695001
India 
Phone  9446591947  
Fax    
Email  drshijirs@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SHIJI R S 
Designation  Professor and HOD 
Affiliation  Govt Ayurveda College Thiruvananthapuram 
Address  Department of Agadatantra Govt Ayurveda College Thiruvananthapuram Kerala

Thiruvananthapuram
KERALA
695001
India 
Phone  9446591947  
Fax    
Email  drshijirs@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda College Thiruvananthapuram Kerala India Pin 695001 
 
Primary Sponsor  
Name  Government Ayurveda College Thiruvananthapuram 
Address  Sukhmi A S Department Of Agadatantra Govt Ayurveda College Thiruvananthapuram  
Type of Sponsor  Other [Govt Ayurveda College] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sukhmi A S  Government Ayurveda College Thiruvananthapuram Kera  Government Ayurveda College Panchakarma Hospital Op no 3 Department of Agadatantra Poojappura 695012 Thiruvananthapuram Kerala
Thiruvananthapuram
KERALA 
9400049752

sukhmiabdulkhadar1990@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE(IEC) Govt Ayurveda College Thiruvananthapuram Kerala India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L439||Lichen planus, unspecified. Ayurveda Condition: KITIBAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: VAJRAKA KASHAYA, Reference: ASHTANGA SANGRAHAM, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -N/A
2Intervention ArmDrugClassical(1) Medicine Name: GANDIRIKADI TAILAM, Reference: CAKRADATTAM, Route: Topical, Dosage Form: Taila, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Muhurmuhu, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -N/A
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Participants presenting with symptoms of Cutaneous lichen planus – erythema / discolouration, hypertrophy, scaling, hyperpigmentation, scarring atrophy and also pruritis
2.Both male and female participants with age limit between 25-65 years
 
 
ExclusionCriteria 
Details  1. Participants with uncontrolled systemic illness - hypertension, diabetes mellitus, thyroid dysfunction.
2. Pregnant women and lactating mothers.
3. Participants under steroidal medication
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Change in the assessment parameters – erythema / discolouration, hypertrophy, scaling, hyperpigmentation, scarring atrophy, pruritis.  0 th day
15 th day
31 st day 
 
Secondary Outcome  
Outcome  TimePoints 
N/A  N/A 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   17/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Skin diseases are the most common health problems worldwide and are caused by social, physical and psychological factors which leads to the impairment in quality of life. Steroids are the drug of choice for cutaneous lichen planus and on prolonged use it produces various local and systemic side effects ranging from mild to severe. Thus an effective treatment is the need of hour 
Close